NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
07/25/2026
Back to search
Official data from USPTO
IMMUNORAD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMMUNORAD
ST13
US500000079253804Class
16, 36, 41, 42, 44
Filing
79253804
Registration
5917326
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
08/18/2026
Trademark type
Word
Nice classes
16, 36, 41, 42, 44
Filing date
12/19/2018
Registration date
11/26/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/25/2026
Last transaction
08/18/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
VILLEJUIF CEDEX, FR
Examiner
COWARD, JEFFERY
Current location
Historical data usage
Holders and representatives
Holders
INSTITUT GUSTAVE-ROUSSY
Representatives
Jennifer C. Debrow Taft Stettinius & Hollister LLP
Technical classification
Nice Classes
Class 16Class 36Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
magazinesnewspapersperiodicalsbrochuresleafletsbooks all in the fields of medicinesurgerycancer treatmentmedical and scientific research
Class 36
Charitable fund-raisingCharitable raising of funds and financial sponsorshipin particular for business partnersof the research for cancer preventioncancer prevention programs and medical equipment and scientific research programs aimed at fighting cancer
Class 41
Education servicesorganizing and conducting of colloquiumsconferencescongressessymposiumsseminars in the fields of medicinesurgerycancer treatmentmedical and scientific research; Training services in the fields of medicinesurgerycancer treatmentmedical and scientific research; organization of competitionsevents and exhibitionsfor cultural or educational purposes; Organizing of cultural shows; Entertainment servicescontinuing radio and television shows in the fields of medicinesurgerycancer treatment and preventionmedical and scientific research; organization of shows for cultural purposes; health club servicesproviding instruction and equipment in the field of physical exercise; Teaching in the fields of medicalsurgical and scientific research; Entertainment servicesorganization of events for cultural or entertainment purposes in the nature of gala parties featuring live showsmusic and food and drinks
Class 42
Scientific and medical research; product research and development of new medical products; Research in bacteriologybiologychemistry; Providing scientific information in the field of cancer control ; clinical research in the field of cancer prevention and treatment; biological research; and laboratory research in the field of bacteriologybiologychemistry related to cancer prevention
Class 44
Hospital services; Medical analysis services for the diagnosis and treatment of cancer; Expert medical advisory services; medical and health care services; medical services in the field of surgery; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical imaging services; radiotherapy services; brachytherapy services; Medical dosimetry services for treating cancer; providing information in the field of cancer treatment
Publications
History of USPTO decisions and trademark events.
32 publications found
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
07/25/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/22/2026
ES75
TEAS SECTION 71 & 15 RECEIVED
04/01/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/26/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/27/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/13/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/19/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/03/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/17/2020
FIMP
FINAL DISPOSITION PROCESSED
03/17/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/26/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/06/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/23/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/10/2019
PUBO
PUBLISHED FOR OPPOSITION
09/10/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/21/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/08/2019
ALIE
ASSIGNED TO LIE
08/07/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/31/2019
RFNT
REFUSAL PROCESSED BY IB
04/12/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/23/2019
RFRR
REFUSAL PROCESSED BY MPU
03/23/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/16/2019
MAFR
APPLICATION FILING RECEIPT MAILED
03/16/2019
CNRT
NON-FINAL ACTION WRITTEN
03/15/2019
DOCK
ASSIGNED TO EXAMINER
03/14/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/12/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/07/2019
Continuous trademark protection
Get notified about every new filing that threatens IMMUNORAD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.